NeuroVigil
NeuroVigil is a global neurotechnology pioneer developing proprietary non-invasive brain monitors and advanced machine learning algorithms. Their technology aims to detect biomarkers of pathologies in asymptomatic individuals, such as those with neurodegeneration, adverse drug side effects, or brain cancer, and to ascertain intent in individuals who cannot otherwise communicate, as requested by the late Dr. Stephen Hawking. The company was founded and is led by Dr. Philip Low, and it markets its iBrain device and SPEARS algorithm. NeuroVigil has garnered research contracts with elite pharmaceutical companies and spearheads an international preventive health conglomerate.
NeuroVigil
NeuroVigil is a global neurotechnology pioneer developing proprietary non-invasive brain monitors and advanced machine learning algorithms. Their technology aims to detect biomarkers of pathologies in asymptomatic individuals, such as those with neurodegeneration, adverse drug side effects, or brain cancer, and to ascertain intent in individuals who cannot otherwise communicate, as requested by the late Dr. Stephen Hawking. The company was founded and is led by Dr. Philip Low, and it markets its iBrain device and SPEARS algorithm. NeuroVigil has garnered research contracts with elite pharmaceutical companies and spearheads an international preventive health conglomerate.